Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
13 cosponsors · 12 D, 1 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Mar 5, 2019
- House Passed May 8, 2019 422–0
- Senate Passed Dec 7, 2020
- House Changes resolved Dec 10, 2020
- President To the President Dec 24, 2020
- President Signed Jan 5, 2021
- Law Jan 5, 2021
The holder of an approved drug application must notify the FDA when a listed patent is invalidated by a court or by the Patent Trial and Appeal Board. The FDA must remove invalidated patents from its list, subject to the 180-day drug exclusivity period.
What it does: CRS summary · Public Law · Jan 5, 2021
Orange Book Transparency Act of 2020
This bill modifies requirements for the Food and Drug Administration (FDA)to list and publish drug patent and exclusivity information. Specifically, the FDA must include on its list certain patent information and must specify each drug exclusivity period that has not concluded.The holder of an approved drug application must notify the FDA when a listed patent is invalidated by a court or by the Patent Trial and Appeal Board. The FDA must remove invalidated patents from its list, subject to the 180-day drug exclusivity period.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Orange Book Transparency Act of 2020
Also known as: Orange Book Transparency Act of 2019
Latest action (Jan 5, 2021): Became Public Law No: 116-290.
Policy area: Health · Origin: House · Introduced: Mar 5, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Mar 5, 2019
- House Passed May 8, 2019 422–0
- Senate Passed Dec 7, 2020
- House Changes resolved Dec 10, 2020
- President To the President Dec 24, 2020
- President Signed Jan 5, 2021
- Law Jan 5, 2021
Final vote · House · May 8, 2019
Passage (two-thirds required) — Passed. Vote details
Speaker of the House: Nancy Pelosi